Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma

Pathology and Oncology Research

Volumn 13, Issue 1, 2007, Pages 21-31

  Kiss, Judit ^a   Tímár, József ^a   Somlai, Beáta ^a   Gilde, Katalin ^a   Fejos, Zsuzsanna ^a   Gaudi, István ^a   Ladányi, Andrea ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Angiogenesis; Immunohistochemistry; Lymphocytes; Macrophages; Microvessel density

Indexed keywords

ARTICLE; CELL DENSITY; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROVASCULATURE; SEX DIFFERENCE; SKIN CANCER; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

EID: 34250028387     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893437     Document Type: Article

References (64)

1. Arici A, Senturk LM, Seli E, Bahtiyar MO, Kim G: Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol Reprod 61: 85-90, 1999
2. Arvilommi AM, Salmi M, Kalimo K, Jalkanen S: Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1). Eur J Immunol 26: 825-833, 1996
3. Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in performed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14: 53-65, 1977
4. Balch CM, Buzaid AC, Soong S-J, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19: 3635-3648, 2001
5. Barnhill RL, Fine JA, Roush GC, Berwick M: Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 78: 427-432, 1996
6. Barnhill RL, Levy MA: Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis. Am J Pathol 143: 99-104, 1993
7. Bröcker EB, Zwadlo G, Holzmann B, Macher E, Sorg C: Inflammatory cell infiltrates in human malignant melanoma at different stages of tumor progression. Int. J. Cancer 41: 562-567, 1988
8. Busam KJ, Berwick M, Blessing K, Fandrey K, Kang S, Karaoli T, Fine J, Cochran AJ, White WL, Rivers J: Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 147: 1049-1056, 1995
9. Clark WH Jr, Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC: Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81: 1893-1904, 1989
10. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N: Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77: 1303-1310, 1996
11. Colombel M, Filleur S, Fournier P, Merle C, Guglielmi J, Courtin A, Degeorges A, Serre CM, Bouvier R, Clezardin P, Cabon F: Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. Cancer Res 65: 300-308, 2005
12. Coukos G, Benencia F, Buckanovich RJ, Conejo-Garcia JR: The role of dendritic cell precursors in tumour vasculogenesis. Br J Cancer 92: 1182-1187, 2005
13. Curiel TJ, Cheng P, Mottram P, Alvarez X, Moons L, Evdemon-Hogan M, Wei S, Zou L, Kryczek I, Hoyle G, Lackner A, Carmeliet P, Zou W: Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res 64: 5535-5538, 2004
14. Davidson B, Goldberg I, Gotlieb WH, Lerner-Geva L, Ben-Baruch G, Agulansky L, Novikov I, Kopolovic J: Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma - clinicopathologic correlation. Acta Obstet Gynecol Scand 78: 240-244, 1999
15. Depasquale I, Thompson WD: Microvessel density for melanoma prognosis. Histopathology 47: 186-194, 2005
16. Dobos J, Tímár J, Bocsi J, Burián Z, Nagy K, Barna G, Peták I, Ladányi A: In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. Int J Cancer 112: 771-776, 2004
17. Döme J, Hendrix MJC, Paku S, Tóvári J, Tímár J: Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am J Pathol, 170: 1-15, 2007
18. Döme B, Paku S, Somlai B, Tímár J: Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance. J Pathol 97: 355-362, 2002
19. Forster-Horváth C, Döme B, Paku S, Ladänyi A, Somlai B, Jalkanen S, Tïmär J: Loss of vascular adhesion protein-1 expression in intratumoral microvessels of human skin melanoma. Melanoma Res 14: 135-140, 2004
20. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L: The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368: 237-239, 1994
21. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M: Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 55: 4140-4145, 1995
22. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2: 1096-1103, 1996
23. Gross J, Azizkhan RG, Biswas C, Bruns RR, Hsieh DS, Folkman J: Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci U S A 78: 1176-1180, 1981
24. Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N, Nomuray: Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7: 263-269, 2000
25. Ilmonen S, Kariniemi AL, Vlaykova T, Muhonen T, Pyrhonen S, Asko-Seljavaara S: Prognostic value of tumour vascularity in primary melanoma. Melanoma Res 9: 273-278, 1999
26. Inoshima N, Nakanishi Y, Minami T, Izumi M, Takayama K, Yoshino I, Hara N: The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Clin Cancer Res 8: 3480-3486, 2002
27. Ishigami S, Aikou T, Natsugoe S, Hokita S, Iwashige H, Tokushige M, Sonoda S: Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 55: 65-69, 1998
28. Ishigami S, Natsugoe S, Matsumoto M, Okumura H, Sakita H, Nakashima S, Takao S, Aikou T: Clinical implications of intra-tumoral dendritic cell infiltration in esophageal squamous cell carcinoma. Oncol Rep 10: 1237-1240, 2003
29. rd: Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. J Clin Oncol 20: 1826-1831, 2002
30. Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, Kleinman HK, Greene GL, Schnaper HW: Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94: 1402-1407, 1996
31. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992
32. Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, Wasserman K, Nakazawa T, Anderson P, Kiessling R: Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity. Eur J Immunol 26:1308-1313, 1996
33. Lackner C, Jukic Z, Tsybrovskyy O, Jatzko G, Wette V, Hoefler G, Klimpfinger M, Denk H, Zatloukal K: Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer. Virchows Arch 445: 160-167, 2004
34. + mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother Epub DOI 10.1007/s00262-007-0286-3, 2007
35. Ladányi A, Somlai B, Gilde K, Fejös Z, Gaudi I, Tímár J: T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clin Cancer Res 10:521-530, 2004
36. Leek RD, Harris AL, Lewis CE: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukoc Biol 56: 423-435, 1994
37. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996
38. Losordo DW, Isner JM: Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol 21: 6-12, 2001
39. Mabjeesh NJ, Willard MT, Frederickson CE, Zhong H, Simons JW: Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/protein kinase B in prostate cancer cells. Clin Cancer Res 9: 2416-2425, 2003
40. Madtes DK, Raines EW, Sakariassen KS, Assoian RK, Sporn MB, Bell GI: Induction of transforming growth factor-alpha in human alveolar macrophages. Cell 53: 285-293, 1988
41. Makitie T, Summanen P, Tarkkanen A, Kivela T: Tumor-infiltrating macrophages (CD68-positive cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 42: 1414-1421, 2001
42. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992
43. Marcoval J, Moreno A, Graells J, Vidal A, Escriba JM, Garcia-Ramirez M, Fabra A: Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol 24: 212-218, 1997
44. Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S: Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74: 181-273, 2000
45. McBride WH: Phenotype and functions of intratumoral macrophages. Biochim Biophys Acta 865: 27-41, 1986
46. McDonald DM, Foss AJE: Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev 19: 109-120, 2002
47. Miescher S, Whiteside TL, Carrel S, von Fliedner V: Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136: 1899-1907, 1986
48. Ono M, Torisu H, Fukushi J-I, Nishie A, Kuwano M: Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother Pharmacol 43: 69-71, 1999
49. Peng SH, Deng H, Yang JF, Xie PP, Li C, Li, Feng DY: Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol 11: 6521-6524, 2005
50. Piras F, Colombari R, Minerba L, Murtas D, Floris C, Maxia C, Corbu A, Perra MT, Sirigu P: The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer 104: 1246-1254, 2005
51. Prehn RT: The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma. Cancer Res 56: 937-940, 1996
52. Pribluda VS, Gubish ER Jr, Lavallee TM, Treston A, Swartz GM, Green SJ: 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 19: 173-179, 2000
53. Qin Z, Schwartzkopff J, Pradera F, Kammertoens T, Seliger B, Pircher H, Blankenstein T: A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells. Cancer Res 63: 4095-4100, 2003
54. Ronan SG, Eng AM, Briele HA, Shioura NN, Das Gupta TK: Thin malignant melanomas with regression and metastases. Arch Dermatol 123: 1326-1330, 1987
55. Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N: Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br J Cancer 78: 1573-1577, 1998
56. Seli E, Pehlivan T, Selam B, Garcia-Velasco J A, Arici A: Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil Steril 77: 542-547, 2002
57. Seo KH, Lee HS, Jung B, Ko HM, Choi JH, Park SJ, Choi IH, Lee HK, Im SY: Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res 64: 6482-6488, 2004
58. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW: Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 95: 1505-1514, 1997
59. Straume O, Salvesen HB, Akslen LA: Angiogenesis is prognostically important in vertical growth phase melanomas. Int J Oncol 15: 595-599, 1999
60. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C: Macrophages and angiogenesis. J Leukoc Biol 55: 410-422, 1994
61. Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, Nishioka Y, Sone S, Kuwano M: Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer 85: 182-188, 2000
62. Varney ML, Johansson SL, Singh RK: Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A. Melanoma Res 15: 417-425, 2005
63. Whiteside TL: Signaling defects in T lymphocytes of patients with malignancy. Cancer Immunol Immunother 48: 346-352, 1999
64. Zou W: Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263-274, 2005